145 related articles for article (PubMed ID: 15095477)
1. Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.
Buerger H; Packeisen J; Boecker A; Tidow N; Kersting C; Bielawski K; Isola J; Yatabe Y; Nakachi K; Boecker W; Brandt B
J Pathol; 2004 May; 203(1):545-50. PubMed ID: 15095477
[TBL] [Abstract][Full Text] [Related]
2. Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development.
Tidow N; Boecker A; Schmidt H; Agelopoulos K; Boecker W; Buerger H; Brandt B
Cancer Res; 2003 Mar; 63(6):1172-8. PubMed ID: 12649171
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.
Brandt B; Meyer-Staeckling S; Schmidt H; Agelopoulos K; Buerger H
Clin Cancer Res; 2006 Dec; 12(24):7252-60. PubMed ID: 17189396
[TBL] [Abstract][Full Text] [Related]
4. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression.
Buerger H; Gebhardt F; Schmidt H; Beckmann A; Hutmacher K; Simon R; Lelle R; Boecker W; Brandt B
Cancer Res; 2000 Feb; 60(4):854-7. PubMed ID: 10706093
[TBL] [Abstract][Full Text] [Related]
5. Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (EGFR) in high grade central osteosarcomas.
Kersting C; Agelopoulos K; Schmidt H; Korsching E; August C; Gosheger G; Dirksen U; Juergens H; Winkelmann W; Brandt B; Bielack S; Buerger H; Gebert C
Genes Chromosomes Cancer; 2008 Aug; 47(8):657-64. PubMed ID: 18464244
[TBL] [Abstract][Full Text] [Related]
6. (CA)n microsatellite polymorphism of ERBB-1 in breast cancer.
Wełnicka-Jaśkiewicz M; Zaczek A; Brandt B; Bielawski KP; Jaśkiewicz J; Konopa K; Jassem J
Eur J Cancer; 2006 Aug; 42(12):1698-701. PubMed ID: 16765588
[TBL] [Abstract][Full Text] [Related]
7. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
[TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma.
Suzuki M; Kageyama S; Shinmura K; Okudela K; Bunai T; Nagura K; Igarashi H; Kiyose S; Mori H; Tao H; Goto M; Takamochi K; Mochizuki T; Suzuki K; Ohashi R; Ogawa H; Yamada T; Niwa H; Tsuneyoshi T; Sugimura H
J Surg Oncol; 2008 Nov; 98(6):457-61. PubMed ID: 18683191
[TBL] [Abstract][Full Text] [Related]
9. EGFR gene and protein expression in breast cancers.
Park K; Han S; Shin E; Kim HJ; Kim JY
Eur J Surg Oncol; 2007 Oct; 33(8):956-60. PubMed ID: 17374474
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
Nomura M; Shigematsu H; Li L; Suzuki M; Takahashi T; Estess P; Siegelman M; Feng Z; Kato H; Marchetti A; Shay JW; Spitz MR; Wistuba II; Minna JD; Gazdar AF
PLoS Med; 2007 Apr; 4(4):e125. PubMed ID: 17455987
[TBL] [Abstract][Full Text] [Related]
12. Association between the length of a CA dinucleotide repeat in the EGFR and risk of breast cancer.
Jami MS; Hemati S; Salehi Z; Tavassoli M
Cancer Invest; 2008 May; 26(4):434-7. PubMed ID: 18443966
[TBL] [Abstract][Full Text] [Related]
13. An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.
Amador ML; Oppenheimer D; Perea S; Maitra A; Cusatis G; Iacobuzio-Donahue C; Baker SD; Ashfaq R; Takimoto C; Forastiere A; Hidalgo M
Cancer Res; 2004 Dec; 64(24):9139-43. PubMed ID: 15604284
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
Zhang W; Park DJ; Lu B; Yang DY; Gordon M; Groshen S; Yun J; Press OA; Vallböhmer D; Rhodes K; Lenz HJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):600-5. PubMed ID: 15701846
[TBL] [Abstract][Full Text] [Related]
15. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
Toyama T; Yamashita H; Kondo N; Okuda K; Takahashi S; Sasaki H; Sugiura H; Iwase H; Fujii Y
BMC Cancer; 2008 Oct; 8():309. PubMed ID: 18950515
[TBL] [Abstract][Full Text] [Related]
16. Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinoma.
Layfield LJ; Bernard PS; Goldstein NS
J Surg Oncol; 2003 Aug; 83(4):227-31. PubMed ID: 12884235
[TBL] [Abstract][Full Text] [Related]
17. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.
Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Vickers SM; Buchsbaum DJ; Heslin MJ; Arnoletti JP
Ann Surg Oncol; 2007 Jul; 14(7):2150-8. PubMed ID: 17453292
[TBL] [Abstract][Full Text] [Related]
19. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
[TBL] [Abstract][Full Text] [Related]
20. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]